“Fewer than 1% of patients taking the drug needed to be hospitalized and no one died. In the comparison group, 7% were hospitalized and there were seven deaths.” So promising that they halted the trial early. Pfizer, like Merck, *must* allow cheap generics for LMIC. No excuses.https://twitter.com/AP/status/1456576002457575427 …
-
Show this thread
-
Replying to @zeynep
What is the other antiviral? “Patients who received the company’s drug along with another antiviral shortly after showing COVID-19 symptoms had an 89% reduction in their combined rate of hospitalization or death after a month, compared to patients taking a dummy pill.”
1 reply 0 retweets 9 likes
Replying to @TheEliKlein
Ritonavir. I believe this is the clinical trial:https://clinicaltrials.gov/ct2/show/NCT04960202 …
1 reply
2 retweets
7 likes
-
Show additional replies, including those that may contain offensive content
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.